Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29118264.
- Also identified by DOI 10.1126/scitranslmed.aam8574.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In response to heart failure (HF), the heart reacts by repressing adult genes and expressing fetal genes, thereby returning to a more fetal-like gene profile. To identify genes involved in this process, we carried out transcriptional analysis on murine hearts at different stages of development and on hearts from adult mice with HF. Our screen identified <i>Oplah</i>, encoding for 5-oxoprolinase, a member of the γ-glutamyl cycle that functions by scavenging 5-oxoproline. OPLAH depletion occurred as a result of cardiac injury, leading to elevated 5-oxoproline and oxidative stress, whereas OPLAH overexpression improved cardiac function after ischemic injury. In HF patients, we observed elevated plasma 5-oxoproline, which was associated with a worse clinical outcome. Understanding and modulating fetal-like genes in the failing heart may lead to potential diagnostic, prognostic, and therapeutic options in HF.
Medical subject headings
- Cardiotonic Agents
- Myocardium
- Pyroglutamate Hydrolase
- Pyrrolidonecarboxylic Acid